• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合 FDG-PET 的标准化摄取值和 DW-MRI 的表观扩散系数可改善头颈部鳞状细胞癌的风险分层。

Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.

机构信息

Department of Radiology, European Institute of Oncology, Milan, Italy.

Specialisation School of Radiology, University of Milan, Milan, Italy.

出版信息

Eur Radiol. 2016 Dec;26(12):4432-4441. doi: 10.1007/s00330-016-4284-8. Epub 2016 Mar 10.

DOI:10.1007/s00330-016-4284-8
PMID:26965504
Abstract

OBJECTIVES

To assess the independent prognostic value of standardized uptake value (SUV) and apparent diffusion coefficient (ADC), separately and combined, in order to evaluate if the combination of these two variables allows further prognostic stratification of patients with head and neck squamous cell carcinomas (HNSCC).

METHODS

Pretreatment SUV and ADC were calculated in 57 patients with HNSCC. Mean follow-up was 21.3 months. Semiquantitative analysis of primary tumours was performed using SUV, ADC, ADC and ADC. The prognostic value of SUV, ADC, ADC and ADC in predicting disease-free survival (DFS) was evaluated with log-rank test and Cox regression models.

RESULTS

Patients with SUV ≥5.75 had an overall worse prognosis (p = 0.003). After adjusting for lymph node status and diameter, SUV and ADC were both significant predictors of DFS with hazard ratio (HR) = 10.37 (95 % CI 1.22-87.95) and 3.26 (95 % CI 1.20-8.85) for SUV ≥5.75 and ADC ≥0.58 × 10 mm/s, respectively. When the analysis was restricted to subjects with SUV ≥5.75, high ADC significantly predicted a worse prognosis, with adjusted HR = 3.11 (95 % CI 1.13-8.55).

CONCLUSIONS

The combination of SUV and ADC improves the prognostic role of the two separate parameters; patients with high SUV and high ADC are associated with a poor prognosis.

KEY POINTS

• High SUV is a poor prognostic factor in HNSCC • High ADC is a poor prognostic factor in HNSCC • In patients with high SUV , high ADC identified those with worse prognosis.

摘要

目的

评估标准化摄取值(SUV)和表观扩散系数(ADC)的独立预后价值,分别和联合,以评估这两个变量的组合是否可以进一步对头颈部鳞状细胞癌(HNSCC)患者进行预后分层。

方法

对 57 例 HNSCC 患者进行 SUV 和 ADC 的预处理。平均随访时间为 21.3 个月。采用 SUV、ADC、ADC 和 ADC 对原发肿瘤进行半定量分析。采用对数秩检验和 Cox 回归模型评估 SUV、ADC、ADC 和 ADC 对无病生存(DFS)的预测价值。

结果

SUV≥5.75 的患者总体预后较差(p=0.003)。在调整淋巴结状态和直径后,SUV 和 ADC 均为 DFS 的显著预测因素,SUV≥5.75 和 ADC≥0.58×10 mm/s 的风险比(HR)分别为 10.37(95%CI 1.22-87.95)和 3.26(95%CI 1.20-8.85)。当分析仅限于 SUV≥5.75 的患者时,高 ADC 显著预测预后不良,调整后的 HR=3.11(95%CI 1.13-8.55)。

结论

SUV 和 ADC 的联合应用提高了两个独立参数的预后作用;SUV 高和 ADC 高的患者预后不良。

关键要点

  1. SUV 高是 HNSCC 的不良预后因素。

  2. ADC 高是 HNSCC 的不良预后因素。

  3. 在 SUV 高的患者中,高 ADC 可识别出预后较差的患者。

相似文献

1
Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.联合 FDG-PET 的标准化摄取值和 DW-MRI 的表观扩散系数可改善头颈部鳞状细胞癌的风险分层。
Eur Radiol. 2016 Dec;26(12):4432-4441. doi: 10.1007/s00330-016-4284-8. Epub 2016 Mar 10.
2
Correlations between DW-MRI and F-FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo-radiotherapy.头颈部鳞状细胞癌根治性放化疗后 DW-MRI 与 F-FDG PET/CT 参数的相关性。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1360. doi: 10.1002/cnr2.1360. Epub 2021 May 7.
3
FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.头颈部鳞状细胞癌的 FDG PET/CT 和弥散加权成像:原发肿瘤标准化摄取值与表观弥散系数之间的预后意义比较。
Clin Nucl Med. 2012 May;37(5):475-80. doi: 10.1097/RLU.0b013e318248524a.
4
Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.头颈部鳞状细胞癌的扩散加权 MRI 和 FDG PET/CT 功能成像:ADC 和 SUV 的定量分析。
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):842-52. doi: 10.1007/s00259-013-2351-9. Epub 2013 Feb 22.
5
Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.同步(18)F-FDG-PET/MRI:头颈部鳞状细胞癌患者扩散、葡萄糖代谢与组织病理学参数之间的关联
Oral Oncol. 2016 Jul;58:14-20. doi: 10.1016/j.oraloncology.2016.04.009. Epub 2016 May 7.
6
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.治疗前 18F-FDG PET/CT 最大标准化摄取值对局部晚期头颈部鳞状细胞癌的预后价值。
Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.
7
Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.全身同步杂交 PET/MRI 评估肿瘤病变的标准化摄取值与表观扩散系数的相关性。
AJR Am J Roentgenol. 2013 Nov;201(5):1115-9. doi: 10.2214/AJR.13.11304.
8
Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.定量扩散加权成像和 18-F-FDG-PET 在头颈部鳞状细胞癌(放化疗)治疗中的预测价值。
Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4.
9
Multiparametric functional MRI and F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation.多参数功能磁共振成像和 F-FDG-PET 预测头颈部鳞状细胞癌患者接受(放)化疗的生存情况。
Eur Radiol. 2021 Feb;31(2):616-628. doi: 10.1007/s00330-020-07163-3. Epub 2020 Aug 26.
10
Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.治疗前MRI最小表观扩散系数值是接受根治性放化疗的宫颈癌患者的一种潜在预后影像生物标志物。
BMC Cancer. 2016 Jul 28;16:556. doi: 10.1186/s12885-016-2619-0.

引用本文的文献

1
Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.在头颈部癌症患者的放射治疗过程中,系列多参数 MRI 和 FDG-PET/CT 功能成像的变化可预测治疗反应。
Eur Radiol. 2023 Dec;33(12):8788-8799. doi: 10.1007/s00330-023-09843-2. Epub 2023 Jul 5.
2
Image-Guided Intraoperative Assessment of Surgical Margins in Oral Cavity Squamous Cell Cancer: A Diagnostic Test Accuracy Review.口腔鳞状细胞癌手术切缘的图像引导术中评估:诊断试验准确性综述
Diagnostics (Basel). 2023 May 25;13(11):1846. doi: 10.3390/diagnostics13111846.
3

本文引用的文献

1
Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.原发肿瘤标准化摄取值可预测头颈部鳞状细胞癌的生存情况。
Oncol Res Treat. 2015;38(1-2):45-8. doi: 10.1159/000370331. Epub 2015 Jan 23.
2
Metal artefact reduction in MRI at both 1.5 and 3.0 T using slice encoding for metal artefact correction and view angle tilting.在1.5T和3.0T磁共振成像中,采用切片编码金属伪影校正和视角倾斜技术减少金属伪影。
Br J Radiol. 2015 Apr;88(1048):20140601. doi: 10.1259/bjr.20140601. Epub 2015 Jan 23.
3
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
The ability of post-chemoradiotherapy DWI ADC and F-FDG SUV to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status.
放化疗后 DWI ADC 值和 F-FDG SUV 值预测头颈部鳞癌治疗效果的能力:人乳头瘤病毒阳性口咽癌状态的影响。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2323-2336. doi: 10.1007/s00432-021-03662-y. Epub 2021 Jun 22.
4
The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient.利用治疗前表观扩散系数预测人乳头瘤病毒状态对头颈部癌放化疗结局的影响
Br J Radiol. 2022 Feb 1;95(1130):20210333. doi: 10.1259/bjr.20210333. Epub 2021 Dec 20.
5
Correlations between DW-MRI and F-FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo-radiotherapy.头颈部鳞状细胞癌根治性放化疗后 DW-MRI 与 F-FDG PET/CT 参数的相关性。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1360. doi: 10.1002/cnr2.1360. Epub 2021 May 7.
6
Prognostic Value of Apparent Diffusion Coefficient in Oropharyngeal Carcinoma.口咽癌表观弥散系数的预后价值。
Clin Neuroradiol. 2021 Dec;31(4):1037-1048. doi: 10.1007/s00062-021-01014-4. Epub 2021 Apr 20.
7
Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic review and meta-analysis.接受原发性放化疗的复发性喉癌和下咽癌的预后影像变量:一项系统评价和荟萃分析。
Head Neck. 2021 Jul;43(7):2202-2215. doi: 10.1002/hed.26698. Epub 2021 Apr 2.
8
Multiple Testing, Cut-Point Optimization, and Signs of Publication Bias in Prognostic FDG-PET Imaging Studies of Head and Neck and Lung Cancer: A Review and Meta-Analysis.头颈部和肺癌预后FDG-PET成像研究中的多重检验、切点优化及发表偏倚迹象:一项综述与荟萃分析
Diagnostics (Basel). 2020 Dec 1;10(12):1030. doi: 10.3390/diagnostics10121030.
9
Imaging biomarkers in upper gastrointestinal cancers.上消化道癌症中的影像生物标志物
BJR Open. 2019 Jun 24;1(1):20190001. doi: 10.1259/bjro.20190001. eCollection 2019.
10
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.基于 ADC 值直方图分析的治疗前弥散加权成像对已知人乳头瘤病毒状态的晚期口咽癌放化疗预后的预测价值。
AJNR Am J Neuroradiol. 2020 Aug;41(8):1473-1479. doi: 10.3174/ajnr.A6695. Epub 2020 Jul 30.
氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描:欧洲核医学与分子影像学会肿瘤显像程序指南:第2.0版。
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.
4
Diffusion-weighted imaging of the head and neck in healthy subjects: reproducibility of ADC values in different MRI systems and repeat sessions.健康受试者头颈部的扩散加权成像:不同MRI系统及重复检查中ADC值的可重复性
AJNR Am J Neuroradiol. 2015 Feb;36(2):384-90. doi: 10.3174/ajnr.A4114. Epub 2014 Sep 25.
5
FDG-PET/CT pitfalls in oncological head and neck imaging.头颈部肿瘤成像中18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG-PET/CT)的陷阱
Insights Imaging. 2014 Oct;5(5):585-602. doi: 10.1007/s13244-014-0349-x. Epub 2014 Aug 26.
6
Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.¹⁸F-FDG-PET/MRI与¹⁸F-FDG-PET/CT在头颈癌患者中的定性和定量性能比较
AJNR Am J Neuroradiol. 2014 Oct;35(10):1970-5. doi: 10.3174/ajnr.A3993. Epub 2014 Jun 12.
7
Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials.两名肉瘤患者的PET/MR混合成像——临床益处及对未来试验的启示
Int J Clin Exp Med. 2014 Mar 15;7(3):640-8. eCollection 2014.
8
Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings.磁共振弥散加权成像在喉癌和下咽癌中的应用:表观弥散系数与组织学发现的相关性。
Radiology. 2014 Aug;272(2):456-63. doi: 10.1148/radiol.14131173. Epub 2014 Apr 17.
9
Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI.头颈部鳞状细胞癌的影像学检查:PET/MRI 的潜在作用。
Br J Radiol. 2014 Apr;87(1036):20130677. doi: 10.1259/bjr.20130677. Epub 2014 Feb 3.
10
Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.将治疗前扩散加权磁共振成像纳入头颈部鳞状细胞癌的多变量预后模型。
Radiother Oncol. 2014 Mar;110(3):429-34. doi: 10.1016/j.radonc.2014.01.004. Epub 2014 Mar 11.